Ozempic: Could Weight-Loss Drugs have Surprising Brain Benefits?
Summary
Hosts Kat and Helen explore the emerging brain health benefits of GLP-1 drugs like Ozempic, moving beyond their use for weight loss and diabetes. They interview neuroscientist Professor Paul Kenny to discuss how these medications may reduce addiction cravings by altering satiety signals and affect motivation. The episode also examines mixed clinical trial results for Alzheimer’s and depression, while addressing concerns about societal shifts in body image and potential side effects.
Topics discussed
Introduction and the rise of GLP-1 drugs
Anecdotal benefits vs. scientific evidence
History of GLP-1s and their widespread use
How GLP-1s suppress appetite in the brain
Impact on addiction and general motivation
Effects on mood, anxiety, and Alzheimer's
Side effects and cultural impact on body image
Future potential for addiction treatment and closing thoughts
Listen ad-free on Castria